https://www.selleckchem.com/products/S31-201.html
People/patients living with human immunodeficiency virus (PLWH) are at an increased risk for atherosclerotic cardiovascular disease due to normal disease processes, antiretroviral medication adverse effects, and age-related comorbid conditions. Preventive cardiovascular (CV) screenings such as the need for statin, low-dose aspirin, or smoking cessation counseling are not well studied in PLWH. To investigate whether there are differences in preventive CV care offered to patients with and without human immunodeficiency virus (HIV) infecti
पसंद करना
टिप्पणी
शेयर करना
